• Study finds many patients are fearful of wasting GPs’ time
    A recent study at Cambridge University has found that the current NHS crisis has left patients reluctant to visit their doctor amid fears they are wasting their GP’s time.
  • CCF-KKH collaboration launches two support programmes for childhood cancer
    Two new programmes have been launched to support child cancer patients during their treatment and beyond, in conjunction with the Children's Cancer Foundation's 25th anniversary celebration.
  • Will an expedited FDA drug-approval process result in a win-win situation?
    Accelerating the FDA drug-approval process has been a broadly bipartisan supported issue. But will it be a win-win situation for patients and pharmaceutical companies?
  • Singapore's MOH to improve palliative care by increasing inpatient beds
    To meet the needs of an ageing population, the Ministry of Health will be upgrading palliative care services through funding as well as increasing inpatient beds by 2020.
  • New transparency rules for pharma companies leave Australian health experts furious
    Pharmaceutical companies were found to spend over AUS$2.6 million on "educational events" for doctors on a new generation of blood thinners, in just six months. To add to concerns, these companies will no longer have to publish information about what they spend on such events.
  • Retracted study puts China's efforts of organ transplant reform in the spotlight
    A study by Chinese surgeons was retracted due to accusations that the research involved livers that were extracted from executed prisoners of conscience. WHO has also announced that China has taken steps to end its once-illegal-widespread practice of harvesting organs from executed prisoners, but critics remain unconvinced.
  • Critics slam FDA's latest DMD drug approval, forces company to pause drug launch
    This week, the US saw the first steroid for DMD being FDA-approved. However, the drug was slated for an inflated price of USD89,000 a year. After Congress and frustrated parents questioned the price hike, the company has paused the drug launch.
  • Man’s pacemaker data leads police to suspect arson
    A man was suspected of arson and insurance fraud after data from his pacemaker pointed to further inconsistencies between his statements and the evidence the police obtained.
  • MOH: Possible spike in dengue cases, Wolbachia-infected mosquitoes not released nationwide yet
    The Malaysian Ministry of Health is predicting a possible spike in the number of dengue cases in July and August, but there are no nationwide plans of releasing mosquitoes containing the Wolbachia bacteria in dengue-affected areas.
  • The role of corporate communications in private clinics
    Most people believe that a corporate communications department is mostly in charge of managing the crowd or situations and that such a department is only necessary for bigger establishments i.e. hospitals in the healthcare sector. However, corporate communications actually have a greater function — to shape the image of a healthcare institution in the eyes of the public.
  • The many facets of rising healthcare costs in Singapore
    According to the Pricewaterhouse Coopers (PwC) Health Research Institute, the projected increase in global medical costs in 2017 is likely to be the same as that of 2016, i.e. 6.5%. However, the situation of rising medical costs appears to be much worse in Singapore, where according to a report, elderly healthcare costs are projected to rise tenfold over the next 15 years to more than US$49 billion (SG$66 billion) annually. 
  • The impacts of the PSS Practice Guide for Minor Ailments for pharmacists
    In 2016, the Pharmaceutical Society of Singapore (PSS) published "The Practice Guide for Minor Ailments”, a collection of guidelines for the 14 most commonly encountered minor ailments in Singapore. This is the first ever local compilation of the sort.
  • Regulator spent £240,000 to cover up negligence leading to babies’ deaths
    At least 11 babies and one mother have died unlawfully at an NHS trust. Now, it has come to light that the NHS trust and other regulating bodies have spent almost £240,000 in an unsuccessful bid to cover up the truth about these deaths.